Many patients, little drugs: Who should get scarce COVID-19 treatments?,

As clinical trials continued, CompAC was kept updated to make its decisions according to the most recent knowledge about the drug’s safety and efficacy …, As clinical trials continued, CompAC was kept updated to make its decisions according to the most recent knowledge about the drug’s safety and efficacy …, Read More

Scroll to Top